Name | Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
---|
Multiple Myeloma | 36 | 2024 | 5196 | 1.890 |
Why?
|
beta Catenin | 3 | 2022 | 1047 | 0.750 |
Why?
|
Neoplasms, Plasma Cell | 1 | 2021 | 38 | 0.730 |
Why?
|
MicroRNAs | 4 | 2021 | 3803 | 0.700 |
Why?
|
B-Lymphocytes | 10 | 2023 | 4793 | 0.660 |
Why?
|
Myeloid Differentiation Factor 88 | 3 | 2019 | 582 | 0.630 |
Why?
|
Apoptosis Regulatory Proteins | 5 | 2024 | 1151 | 0.610 |
Why?
|
Lymphoma, Large B-Cell, Diffuse | 3 | 2023 | 1437 | 0.570 |
Why?
|
Cyclophilin A | 2 | 2023 | 57 | 0.540 |
Why?
|
Plasma Cells | 5 | 2021 | 599 | 0.540 |
Why?
|
Waldenstrom Macroglobulinemia | 8 | 2020 | 1077 | 0.510 |
Why?
|
Amino Acid Substitution | 2 | 2019 | 1743 | 0.510 |
Why?
|
Leukemia, Lymphocytic, Chronic, B-Cell | 6 | 2023 | 1642 | 0.500 |
Why?
|
bcl-2 Homologous Antagonist-Killer Protein | 1 | 2015 | 71 | 0.490 |
Why?
|
Bone Marrow | 10 | 2023 | 2935 | 0.490 |
Why?
|
Drug Resistance, Neoplasm | 13 | 2024 | 5341 | 0.480 |
Why?
|
Cell Proliferation | 19 | 2024 | 10474 | 0.470 |
Why?
|
bcl-2-Associated X Protein | 1 | 2015 | 281 | 0.460 |
Why?
|
Neoplasm Proteins | 6 | 2022 | 3603 | 0.450 |
Why?
|
Cell Transformation, Neoplastic | 2 | 2019 | 2846 | 0.410 |
Why?
|
Transcription Factors | 9 | 2022 | 12168 | 0.400 |
Why?
|
Gene Expression Regulation, Neoplastic | 14 | 2021 | 8647 | 0.370 |
Why?
|
Colorectal Neoplasms | 2 | 2022 | 6974 | 0.370 |
Why?
|
Cell Line, Tumor | 25 | 2024 | 17140 | 0.350 |
Why?
|
Mice | 39 | 2024 | 82029 | 0.330 |
Why?
|
Dexamethasone | 3 | 2015 | 1965 | 0.320 |
Why?
|
Boronic Acids | 8 | 2014 | 915 | 0.300 |
Why?
|
Pyrazines | 9 | 2021 | 1205 | 0.300 |
Why?
|
Jumonji Domain-Containing Histone Demethylases | 2 | 2021 | 168 | 0.290 |
Why?
|
Apoptosis | 16 | 2023 | 9523 | 0.290 |
Why?
|
Mice, SCID | 12 | 2021 | 2627 | 0.260 |
Why?
|
Xenograft Model Antitumor Assays | 9 | 2021 | 3611 | 0.260 |
Why?
|
Epoxy Compounds | 2 | 2018 | 137 | 0.250 |
Why?
|
Receptors, CXCR4 | 4 | 2020 | 729 | 0.250 |
Why?
|
Animals | 42 | 2024 | 169246 | 0.240 |
Why?
|
Mutation | 7 | 2021 | 30238 | 0.240 |
Why?
|
Chromosome Deletion | 2 | 2021 | 1385 | 0.240 |
Why?
|
Proto-Oncogene Proteins | 3 | 2018 | 4528 | 0.240 |
Why?
|
Precancerous Conditions | 2 | 2011 | 985 | 0.230 |
Why?
|
Chromosome Aberrations | 1 | 2011 | 1778 | 0.230 |
Why?
|
NF-kappa B | 7 | 2021 | 2493 | 0.230 |
Why?
|
Lymphoma, Extranodal NK-T-Cell | 1 | 2024 | 53 | 0.220 |
Why?
|
Cell Movement | 7 | 2016 | 5210 | 0.200 |
Why?
|
Lymphoma, T-Cell, Cutaneous | 2 | 2024 | 210 | 0.200 |
Why?
|
3' Untranslated Regions | 2 | 2015 | 515 | 0.200 |
Why?
|
Gene Deletion | 2 | 2021 | 2675 | 0.200 |
Why?
|
Antineoplastic Agents | 10 | 2024 | 13676 | 0.200 |
Why?
|
Cell Adhesion | 8 | 2016 | 3096 | 0.200 |
Why?
|
DNA-Binding Proteins | 5 | 2018 | 9615 | 0.190 |
Why?
|
Histone Deacetylase Inhibitors | 2 | 2017 | 778 | 0.190 |
Why?
|
Tumor Cells, Cultured | 11 | 2021 | 6124 | 0.190 |
Why?
|
Protease Inhibitors | 4 | 2013 | 751 | 0.180 |
Why?
|
Endoplasmic Reticulum | 1 | 2007 | 1133 | 0.180 |
Why?
|
Chromosomes, Human, Pair 13 | 1 | 2021 | 192 | 0.180 |
Why?
|
Tumor Burden | 3 | 2017 | 1906 | 0.180 |
Why?
|
Plasmacytoma | 1 | 2021 | 170 | 0.180 |
Why?
|
Leukemia, Myelomonocytic, Chronic | 1 | 2021 | 93 | 0.170 |
Why?
|
Proteasome Endopeptidase Complex | 3 | 2023 | 1319 | 0.170 |
Why?
|
Nuclear Envelope | 1 | 2021 | 163 | 0.170 |
Why?
|
Ubiquitin Thiolesterase | 2 | 2013 | 465 | 0.170 |
Why?
|
Phosphoproteins | 3 | 2019 | 2451 | 0.170 |
Why?
|
Adaptor Proteins, Signal Transducing | 2 | 2024 | 2909 | 0.160 |
Why?
|
Cell Communication | 3 | 2020 | 1660 | 0.160 |
Why?
|
Ikaros Transcription Factor | 1 | 2021 | 233 | 0.160 |
Why?
|
Receptors, Antigen, B-Cell | 2 | 2021 | 547 | 0.160 |
Why?
|
Mycosis Fungoides | 1 | 2021 | 169 | 0.160 |
Why?
|
Nanoparticles | 2 | 2023 | 1985 | 0.160 |
Why?
|
Microtubule-Associated Proteins | 1 | 2024 | 1074 | 0.160 |
Why?
|
Dura Mater | 1 | 2021 | 293 | 0.160 |
Why?
|
Nerve Sheath Neoplasms | 1 | 2020 | 169 | 0.160 |
Why?
|
Humans | 69 | 2024 | 768166 | 0.150 |
Why?
|
Disease Models, Animal | 6 | 2021 | 18349 | 0.150 |
Why?
|
Mice, Inbred NOD | 3 | 2021 | 1837 | 0.150 |
Why?
|
Chromosome Disorders | 1 | 2021 | 498 | 0.150 |
Why?
|
Immunophenotyping | 3 | 2019 | 1864 | 0.150 |
Why?
|
Epstein-Barr Virus Infections | 1 | 2024 | 617 | 0.150 |
Why?
|
Scalp | 1 | 2021 | 391 | 0.150 |
Why?
|
Cytokinesis | 1 | 2019 | 170 | 0.150 |
Why?
|
Multigene Family | 1 | 2021 | 1081 | 0.150 |
Why?
|
Transaminases | 1 | 2018 | 199 | 0.150 |
Why?
|
Signal Transduction | 12 | 2021 | 23645 | 0.150 |
Why?
|
Macrolides | 1 | 2018 | 204 | 0.140 |
Why?
|
RNA Interference | 3 | 2015 | 2832 | 0.140 |
Why?
|
Receptor, Fibroblast Growth Factor, Type 1 | 1 | 2018 | 259 | 0.140 |
Why?
|
DNA Damage | 3 | 2019 | 2469 | 0.140 |
Why?
|
Transcription, Genetic | 3 | 2021 | 7608 | 0.140 |
Why?
|
Terphenyl Compounds | 1 | 2016 | 7 | 0.140 |
Why?
|
Protein-Arginine N-Methyltransferases | 1 | 2017 | 129 | 0.140 |
Why?
|
TNF-Related Apoptosis-Inducing Ligand | 1 | 2018 | 195 | 0.140 |
Why?
|
Endothelial Cells | 3 | 2024 | 3589 | 0.140 |
Why?
|
Genomic Instability | 3 | 2019 | 716 | 0.140 |
Why?
|
Bone Marrow Cells | 5 | 2024 | 2414 | 0.140 |
Why?
|
Receptors, Notch | 1 | 2021 | 751 | 0.140 |
Why?
|
Alternative Splicing | 2 | 2019 | 1105 | 0.130 |
Why?
|
Mice, Transgenic | 5 | 2019 | 9561 | 0.130 |
Why?
|
Up-Regulation | 4 | 2021 | 4146 | 0.130 |
Why?
|
Receptors, Immunologic | 2 | 2021 | 1418 | 0.130 |
Why?
|
Benzylidene Compounds | 1 | 2016 | 25 | 0.130 |
Why?
|
Proto-Oncogene Proteins c-myc | 1 | 2021 | 998 | 0.130 |
Why?
|
Stromal Cells | 6 | 2012 | 1336 | 0.130 |
Why?
|
Wnt Proteins | 1 | 2020 | 725 | 0.130 |
Why?
|
Genetic Association Studies | 3 | 2019 | 2744 | 0.130 |
Why?
|
Lymphoma, Non-Hodgkin | 1 | 2023 | 1375 | 0.120 |
Why?
|
Cell Differentiation | 6 | 2017 | 11669 | 0.120 |
Why?
|
Tumor Suppressor Protein p53 | 3 | 2019 | 2954 | 0.120 |
Why?
|
Membrane Glycoproteins | 3 | 2016 | 3711 | 0.120 |
Why?
|
Skin Neoplasms | 3 | 2024 | 5863 | 0.120 |
Why?
|
Interferon Regulatory Factors | 1 | 2016 | 271 | 0.110 |
Why?
|
Oncogene Proteins, Fusion | 2 | 2021 | 1613 | 0.110 |
Why?
|
Gene Expression | 4 | 2019 | 7598 | 0.110 |
Why?
|
Piperidones | 1 | 2013 | 37 | 0.110 |
Why?
|
Hydroxamic Acids | 1 | 2016 | 483 | 0.110 |
Why?
|
Neoplasms, Experimental | 1 | 2019 | 1230 | 0.110 |
Why?
|
Glucocorticoid-Induced TNFR-Related Protein | 1 | 2013 | 40 | 0.110 |
Why?
|
Intracellular Signaling Peptides and Proteins | 3 | 2019 | 2892 | 0.110 |
Why?
|
Homeostasis | 2 | 2022 | 3348 | 0.110 |
Why?
|
Cholesterol | 1 | 2022 | 2914 | 0.100 |
Why?
|
Kruppel-Like Transcription Factors | 1 | 2016 | 507 | 0.100 |
Why?
|
Sirtuins | 1 | 2015 | 322 | 0.100 |
Why?
|
Thiophenes | 2 | 2018 | 570 | 0.100 |
Why?
|
Glutamic Acid | 1 | 2018 | 1191 | 0.100 |
Why?
|
Neoplasm Transplantation | 2 | 2014 | 2014 | 0.100 |
Why?
|
Cyclohexanones | 1 | 2012 | 30 | 0.100 |
Why?
|
Down-Regulation | 4 | 2014 | 2937 | 0.100 |
Why?
|
Sulfonamides | 2 | 2021 | 1982 | 0.100 |
Why?
|
Tumor Microenvironment | 6 | 2024 | 3948 | 0.100 |
Why?
|
Nuclear Proteins | 1 | 2007 | 5804 | 0.100 |
Why?
|
Liver Transplantation | 1 | 2024 | 2401 | 0.100 |
Why?
|
Ephrin-B2 | 1 | 2011 | 40 | 0.100 |
Why?
|
Receptors, Eph Family | 1 | 2011 | 45 | 0.100 |
Why?
|
Repressor Proteins | 2 | 2017 | 2982 | 0.100 |
Why?
|
Neoplasm Invasiveness | 3 | 2021 | 3620 | 0.090 |
Why?
|
Mice, Inbred C57BL | 4 | 2021 | 22379 | 0.090 |
Why?
|
I-kappa B Kinase | 2 | 2009 | 250 | 0.090 |
Why?
|
Antineoplastic Combined Chemotherapy Protocols | 4 | 2021 | 11878 | 0.090 |
Why?
|
Biopsy | 2 | 2019 | 6793 | 0.090 |
Why?
|
Cell Survival | 5 | 2016 | 5777 | 0.090 |
Why?
|
Trans-Activators | 2 | 2017 | 2857 | 0.090 |
Why?
|
Pyrimidines | 4 | 2019 | 3048 | 0.080 |
Why?
|
Leukemia, Myeloid, Acute | 2 | 2018 | 3626 | 0.080 |
Why?
|
Langerhans Cells | 1 | 2010 | 169 | 0.080 |
Why?
|
Genes, Tumor Suppressor | 1 | 2014 | 1062 | 0.080 |
Why?
|
Protein Binding | 2 | 2020 | 9343 | 0.080 |
Why?
|
Head and Neck Neoplasms | 2 | 2021 | 2931 | 0.080 |
Why?
|
P-Selectin | 1 | 2011 | 598 | 0.080 |
Why?
|
Proto-Oncogene Proteins c-maf | 1 | 2009 | 69 | 0.080 |
Why?
|
Flavones | 1 | 2009 | 66 | 0.080 |
Why?
|
Neoplasm Metastasis | 2 | 2020 | 4912 | 0.080 |
Why?
|
Multiprotein Complexes | 1 | 2015 | 1110 | 0.080 |
Why?
|
Gene Knockdown Techniques | 3 | 2021 | 1606 | 0.080 |
Why?
|
Nerve Tissue Proteins | 1 | 2021 | 4413 | 0.080 |
Why?
|
Alleles | 1 | 2019 | 6894 | 0.080 |
Why?
|
Immunohistochemistry | 2 | 2019 | 11095 | 0.080 |
Why?
|
Proto-Oncogene Proteins c-bcl-2 | 3 | 2023 | 1406 | 0.070 |
Why?
|
Azepines | 1 | 2010 | 329 | 0.070 |
Why?
|
Genes, Regulator | 1 | 2009 | 373 | 0.070 |
Why?
|
Dromaiidae | 1 | 2007 | 7 | 0.070 |
Why?
|
Hypergammaglobulinemia | 1 | 2007 | 71 | 0.070 |
Why?
|
Epithelial-Mesenchymal Transition | 1 | 2012 | 757 | 0.070 |
Why?
|
Cyclin D1 | 1 | 2009 | 453 | 0.070 |
Why?
|
Binding Sites | 1 | 2015 | 6020 | 0.070 |
Why?
|
Electrophoretic Mobility Shift Assay | 1 | 2007 | 294 | 0.070 |
Why?
|
Calcium | 1 | 2020 | 5792 | 0.070 |
Why?
|
Doxorubicin | 4 | 2015 | 2234 | 0.070 |
Why?
|
Drug Synergism | 3 | 2017 | 1760 | 0.060 |
Why?
|
Neoplastic Stem Cells | 1 | 2014 | 1351 | 0.060 |
Why?
|
Lung Neoplasms | 2 | 2023 | 13586 | 0.060 |
Why?
|
Tumor Suppressor Proteins | 2 | 2013 | 2810 | 0.060 |
Why?
|
Chromosomal Instability | 1 | 2006 | 176 | 0.060 |
Why?
|
Carcinoma, Non-Small-Cell Lung | 1 | 2023 | 5432 | 0.060 |
Why?
|
Transplantation, Heterologous | 5 | 2012 | 2393 | 0.060 |
Why?
|
HEK293 Cells | 1 | 2014 | 4283 | 0.060 |
Why?
|
Antigen Presentation | 1 | 2010 | 1251 | 0.060 |
Why?
|
Antigens, Surface | 1 | 2009 | 1617 | 0.060 |
Why?
|
Histones | 3 | 2024 | 2601 | 0.060 |
Why?
|
T-Lymphocytes, Cytotoxic | 1 | 2011 | 1801 | 0.060 |
Why?
|
Mitochondria | 2 | 2018 | 3681 | 0.060 |
Why?
|
Bone Diseases | 1 | 2007 | 416 | 0.050 |
Why?
|
Glioma | 1 | 2018 | 3503 | 0.050 |
Why?
|
Extracellular Signal-Regulated MAP Kinases | 2 | 2021 | 615 | 0.050 |
Why?
|
Genetic Predisposition to Disease | 3 | 2019 | 18065 | 0.050 |
Why?
|
Calreticulin | 1 | 2024 | 115 | 0.050 |
Why?
|
Base Sequence | 1 | 2014 | 12421 | 0.050 |
Why?
|
Intercellular Signaling Peptides and Proteins | 1 | 2010 | 1656 | 0.050 |
Why?
|
Protein Kinase Inhibitors | 3 | 2019 | 5703 | 0.050 |
Why?
|
RNA, Small Interfering | 3 | 2023 | 3428 | 0.050 |
Why?
|
RNA Splicing | 1 | 2007 | 905 | 0.050 |
Why?
|
Hematologic Neoplasms | 1 | 2014 | 1907 | 0.050 |
Why?
|
Proto-Oncogene Proteins c-akt | 2 | 2009 | 2457 | 0.050 |
Why?
|
bcl-X Protein | 1 | 2023 | 412 | 0.050 |
Why?
|
Macrophages | 1 | 2017 | 5799 | 0.050 |
Why?
|
Leukocytes, Mononuclear | 2 | 2023 | 1854 | 0.050 |
Why?
|
TNF Receptor-Associated Factor 2 | 1 | 2021 | 56 | 0.050 |
Why?
|
Daptomycin | 1 | 2021 | 71 | 0.050 |
Why?
|
Prognosis | 6 | 2021 | 30010 | 0.050 |
Why?
|
Gallbladder Neoplasms | 1 | 2002 | 190 | 0.040 |
Why?
|
Immunoprecipitation | 2 | 2014 | 874 | 0.040 |
Why?
|
Loss of Heterozygosity | 1 | 2002 | 663 | 0.040 |
Why?
|
Blotting, Western | 3 | 2014 | 5027 | 0.040 |
Why?
|
Haplotypes | 1 | 2006 | 2722 | 0.040 |
Why?
|
Nuclear Pore Complex Proteins | 1 | 2021 | 165 | 0.040 |
Why?
|
Pyrazoles | 2 | 2021 | 2028 | 0.040 |
Why?
|
Antigens, CD | 1 | 2010 | 4035 | 0.040 |
Why?
|
Neovascularization, Pathologic | 2 | 2024 | 2631 | 0.040 |
Why?
|
Mammary Neoplasms, Experimental | 1 | 2002 | 506 | 0.040 |
Why?
|
Nucleotidyltransferases | 1 | 2021 | 242 | 0.040 |
Why?
|
Mice, Knockout | 4 | 2021 | 14488 | 0.040 |
Why?
|
Cells, Cultured | 3 | 2011 | 19015 | 0.040 |
Why?
|
Pyrimidinones | 1 | 2021 | 386 | 0.040 |
Why?
|
Herpesvirus 4, Human | 1 | 2024 | 1082 | 0.040 |
Why?
|
Peptide Fragments | 1 | 2011 | 5151 | 0.040 |
Why?
|
Skin Diseases | 1 | 2007 | 1085 | 0.040 |
Why?
|
Mitogen-Activated Protein Kinase Kinases | 1 | 2021 | 637 | 0.040 |
Why?
|
Dendritic Cells | 1 | 2009 | 2747 | 0.040 |
Why?
|
Spliceosomes | 1 | 2018 | 116 | 0.040 |
Why?
|
Ubiquitin | 1 | 2023 | 843 | 0.040 |
Why?
|
Mice, 129 Strain | 1 | 2019 | 369 | 0.040 |
Why?
|
Facial Neoplasms | 1 | 1999 | 126 | 0.040 |
Why?
|
Cell Cycle | 3 | 2011 | 2932 | 0.040 |
Why?
|
Chemotaxis | 2 | 2012 | 600 | 0.040 |
Why?
|
Phenanthrolines | 1 | 2017 | 49 | 0.040 |
Why?
|
Phosphorylation | 4 | 2009 | 8317 | 0.040 |
Why?
|
Pregnancy Proteins | 1 | 2018 | 222 | 0.040 |
Why?
|
Minor Histocompatibility Antigens | 1 | 2018 | 303 | 0.040 |
Why?
|
Oxadiazoles | 1 | 2017 | 94 | 0.030 |
Why?
|
Telomerase | 1 | 2002 | 751 | 0.030 |
Why?
|
Glutarates | 1 | 2018 | 242 | 0.030 |
Why?
|
Female | 15 | 2021 | 397192 | 0.030 |
Why?
|
Genetic Testing | 1 | 2009 | 3591 | 0.030 |
Why?
|
ets-Domain Protein Elk-1 | 1 | 2015 | 38 | 0.030 |
Why?
|
Autophagy | 1 | 2024 | 1349 | 0.030 |
Why?
|
Kidney Diseases | 1 | 2007 | 2100 | 0.030 |
Why?
|
Isoquinolines | 1 | 2017 | 354 | 0.030 |
Why?
|
Drug Screening Assays, Antitumor | 1 | 2018 | 719 | 0.030 |
Why?
|
Genes, myc | 1 | 2017 | 391 | 0.030 |
Why?
|
Mice, Mutant Strains | 1 | 2019 | 1754 | 0.030 |
Why?
|
Aniline Compounds | 1 | 2021 | 1094 | 0.030 |
Why?
|
Laryngeal Neoplasms | 1 | 1999 | 514 | 0.030 |
Why?
|
Cell Lineage | 1 | 2024 | 2575 | 0.030 |
Why?
|
Ribonucleoproteins | 1 | 2017 | 359 | 0.030 |
Why?
|
Immunity | 1 | 2021 | 1003 | 0.030 |
Why?
|
Mutagens | 1 | 2015 | 181 | 0.030 |
Why?
|
Case-Control Studies | 4 | 2019 | 22291 | 0.030 |
Why?
|
Surface Properties | 1 | 2018 | 1166 | 0.030 |
Why?
|
Radiation Dosage | 1 | 2023 | 1967 | 0.030 |
Why?
|
Octamer Transcription Factor-2 | 1 | 2014 | 7 | 0.030 |
Why?
|
Interferon-alpha | 1 | 1999 | 910 | 0.030 |
Why?
|
Killer Cells, Natural | 1 | 2024 | 2211 | 0.030 |
Why?
|
Inhibitor of Differentiation Protein 2 | 1 | 2014 | 30 | 0.030 |
Why?
|
Lymphoma, B-Cell, Marginal Zone | 1 | 2015 | 180 | 0.030 |
Why?
|
RNA-Binding Proteins | 1 | 2023 | 1890 | 0.030 |
Why?
|
Male | 11 | 2024 | 364719 | 0.030 |
Why?
|
Macrophage Activation | 1 | 2017 | 557 | 0.030 |
Why?
|
Hemangioma | 1 | 1999 | 727 | 0.030 |
Why?
|
Particle Size | 1 | 2018 | 1649 | 0.030 |
Why?
|
Monoclonal Gammopathy of Undetermined Significance | 1 | 2015 | 179 | 0.030 |
Why?
|
Anilides | 1 | 2016 | 413 | 0.030 |
Why?
|
Proto-Oncogene Proteins c-abl | 1 | 2014 | 145 | 0.030 |
Why?
|
Phosphatidylinositol 3-Kinases | 1 | 2023 | 2885 | 0.030 |
Why?
|
Receptor Protein-Tyrosine Kinases | 1 | 2021 | 1627 | 0.030 |
Why?
|
Adenine | 1 | 2019 | 995 | 0.030 |
Why?
|
Acetylation | 1 | 2015 | 1056 | 0.030 |
Why?
|
Tubulin | 1 | 2016 | 695 | 0.030 |
Why?
|
Granulocyte Precursor Cells | 1 | 2012 | 49 | 0.030 |
Why?
|
Enzyme-Linked Immunosorbent Assay | 2 | 2011 | 3814 | 0.030 |
Why?
|
Amino Acid Chloromethyl Ketones | 1 | 2012 | 68 | 0.030 |
Why?
|
Active Transport, Cell Nucleus | 1 | 2014 | 432 | 0.030 |
Why?
|
Translocation, Genetic | 1 | 2018 | 1394 | 0.030 |
Why?
|
Ubiquitination | 1 | 2017 | 1009 | 0.030 |
Why?
|
Topoisomerase II Inhibitors | 1 | 2012 | 94 | 0.030 |
Why?
|
Oxidation-Reduction | 1 | 2018 | 2227 | 0.020 |
Why?
|
Aged | 7 | 2024 | 171504 | 0.020 |
Why?
|
Isocitrate Dehydrogenase | 1 | 2018 | 951 | 0.020 |
Why?
|
Lipids | 1 | 2023 | 3343 | 0.020 |
Why?
|
Sequence Analysis, DNA | 2 | 2015 | 4786 | 0.020 |
Why?
|
Cyclin-Dependent Kinase Inhibitor p21 | 1 | 2012 | 379 | 0.020 |
Why?
|
Benzamides | 1 | 2017 | 1379 | 0.020 |
Why?
|
Phagocytosis | 1 | 2017 | 1530 | 0.020 |
Why?
|
Polymerase Chain Reaction | 2 | 2015 | 6082 | 0.020 |
Why?
|
Lysine | 1 | 2015 | 1000 | 0.020 |
Why?
|
Carcinoma | 1 | 2002 | 2332 | 0.020 |
Why?
|
Glycolipids | 1 | 2011 | 205 | 0.020 |
Why?
|
Immunoglobulin M | 1 | 2015 | 1528 | 0.020 |
Why?
|
RANK Ligand | 1 | 2012 | 321 | 0.020 |
Why?
|
Oligonucleotide Array Sequence Analysis | 2 | 2009 | 3800 | 0.020 |
Why?
|
Epigenesis, Genetic | 1 | 2024 | 3833 | 0.020 |
Why?
|
Aging | 2 | 2007 | 8744 | 0.020 |
Why?
|
Piperidines | 1 | 2019 | 1667 | 0.020 |
Why?
|
Proto-Oncogene Proteins c-mdm2 | 1 | 2012 | 362 | 0.020 |
Why?
|
Contrast Media | 1 | 2023 | 5330 | 0.020 |
Why?
|
Carrier Proteins | 1 | 2023 | 4937 | 0.020 |
Why?
|
DNA Primers | 1 | 2014 | 2828 | 0.020 |
Why?
|
Fluorescent Antibody Technique | 1 | 2014 | 2474 | 0.020 |
Why?
|
Flow Cytometry | 2 | 2011 | 5902 | 0.020 |
Why?
|
Receptor-Interacting Protein Serine-Threonine Kinase 2 | 1 | 2009 | 32 | 0.020 |
Why?
|
Aged, 80 and over | 4 | 2018 | 59629 | 0.020 |
Why?
|
Cell Hypoxia | 1 | 2012 | 662 | 0.020 |
Why?
|
Breast Neoplasms | 1 | 2017 | 21206 | 0.020 |
Why?
|
Proteomics | 1 | 2023 | 3912 | 0.020 |
Why?
|
Membrane Proteins | 2 | 2021 | 7876 | 0.020 |
Why?
|
Cyclin-Dependent Kinase Inhibitor Proteins | 1 | 2009 | 53 | 0.020 |
Why?
|
Classification | 1 | 2009 | 128 | 0.020 |
Why?
|
Culture Media, Serum-Free | 1 | 2009 | 148 | 0.020 |
Why?
|
Electrophoresis, Capillary | 1 | 2009 | 63 | 0.020 |
Why?
|
Cytogenetic Analysis | 1 | 2009 | 271 | 0.020 |
Why?
|
Gene Expression Profiling | 3 | 2009 | 9538 | 0.020 |
Why?
|
Neoplasms | 1 | 2018 | 22371 | 0.020 |
Why?
|
Colony-Forming Units Assay | 1 | 2009 | 351 | 0.020 |
Why?
|
MAP Kinase Signaling System | 1 | 2015 | 1494 | 0.020 |
Why?
|
Jurkat Cells | 1 | 2010 | 740 | 0.020 |
Why?
|
I-kappa B Proteins | 1 | 2009 | 210 | 0.020 |
Why?
|
CpG Islands | 1 | 2013 | 1208 | 0.020 |
Why?
|
Immunoenzyme Techniques | 1 | 2011 | 1703 | 0.020 |
Why?
|
Clinical Trials, Phase I as Topic | 1 | 2010 | 330 | 0.020 |
Why?
|
Osteoclasts | 1 | 2012 | 713 | 0.020 |
Why?
|
Proteins | 1 | 2023 | 6009 | 0.020 |
Why?
|
Models, Biological | 2 | 2015 | 9495 | 0.020 |
Why?
|
Oligodeoxyribonucleotides | 1 | 2009 | 705 | 0.020 |
Why?
|
Toll-Like Receptor 2 | 1 | 2010 | 348 | 0.020 |
Why?
|
Random Allocation | 1 | 2012 | 2396 | 0.020 |
Why?
|
Mitogen-Activated Protein Kinase 3 | 1 | 2009 | 474 | 0.020 |
Why?
|
Clinical Trials, Phase II as Topic | 1 | 2010 | 640 | 0.020 |
Why?
|
Survival Rate | 1 | 2021 | 12840 | 0.020 |
Why?
|
Mitogen-Activated Protein Kinase 1 | 1 | 2009 | 478 | 0.020 |
Why?
|
Cadherins | 1 | 2012 | 905 | 0.020 |
Why?
|
Thalidomide | 1 | 2012 | 886 | 0.020 |
Why?
|
Phosphorylcholine | 1 | 2007 | 153 | 0.020 |
Why?
|
Immunoglobulins | 1 | 2010 | 855 | 0.020 |
Why?
|
Drug Delivery Systems | 1 | 2018 | 2232 | 0.020 |
Why?
|
DNA Repair | 1 | 2015 | 2050 | 0.020 |
Why?
|
Survival Analysis | 1 | 2019 | 10101 | 0.020 |
Why?
|
Toll-Like Receptors | 1 | 2009 | 582 | 0.020 |
Why?
|
Lentivirus | 1 | 2009 | 518 | 0.020 |
Why?
|
Caspases | 1 | 2009 | 882 | 0.020 |
Why?
|
Immunoblotting | 1 | 2009 | 1647 | 0.020 |
Why?
|
Microscopy, Confocal | 1 | 2011 | 1972 | 0.020 |
Why?
|
Coculture Techniques | 1 | 2009 | 1340 | 0.020 |
Why?
|
Analysis of Variance | 1 | 2014 | 6229 | 0.020 |
Why?
|
Protein Subunits | 1 | 2009 | 943 | 0.020 |
Why?
|
Disease Progression | 2 | 2013 | 13671 | 0.020 |
Why?
|
Gene Expression Regulation, Enzymologic | 1 | 2010 | 1169 | 0.020 |
Why?
|
Retinoblastoma Protein | 1 | 2009 | 671 | 0.020 |
Why?
|
Proto-Oncogene Proteins p21(ras) | 1 | 2013 | 1767 | 0.020 |
Why?
|
Adult | 5 | 2021 | 223646 | 0.010 |
Why?
|
High-Throughput Nucleotide Sequencing | 1 | 2017 | 3671 | 0.010 |
Why?
|
Cytokines | 2 | 2010 | 7453 | 0.010 |
Why?
|
STAT3 Transcription Factor | 1 | 2009 | 874 | 0.010 |
Why?
|
Molecular Targeted Therapy | 1 | 2016 | 2830 | 0.010 |
Why?
|
Genetic Vectors | 1 | 2014 | 3402 | 0.010 |
Why?
|
Neovascularization, Physiologic | 1 | 2011 | 1369 | 0.010 |
Why?
|
Drug Evaluation, Preclinical | 1 | 2009 | 1338 | 0.010 |
Why?
|
Cell Line | 2 | 2009 | 15597 | 0.010 |
Why?
|
Microfilament Proteins | 1 | 2009 | 1133 | 0.010 |
Why?
|
Antibodies, Monoclonal | 1 | 2020 | 9263 | 0.010 |
Why?
|
Middle Aged | 5 | 2018 | 223492 | 0.010 |
Why?
|
Enzyme Activation | 1 | 2009 | 3590 | 0.010 |
Why?
|
Statistics, Nonparametric | 1 | 2009 | 2862 | 0.010 |
Why?
|
Ligands | 1 | 2010 | 3284 | 0.010 |
Why?
|
Anti-Bacterial Agents | 1 | 2021 | 7477 | 0.010 |
Why?
|
Transcriptional Activation | 1 | 2009 | 1750 | 0.010 |
Why?
|
Neoplasm Recurrence, Local | 1 | 2021 | 9419 | 0.010 |
Why?
|
9,10-Dimethyl-1,2-benzanthracene | 1 | 2002 | 58 | 0.010 |
Why?
|
Drug Therapy, Combination | 1 | 2012 | 6316 | 0.010 |
Why?
|
Image Interpretation, Computer-Assisted | 1 | 2015 | 3390 | 0.010 |
Why?
|
Promoter Regions, Genetic | 1 | 2013 | 5797 | 0.010 |
Why?
|
Reverse Transcriptase Polymerase Chain Reaction | 1 | 2009 | 4580 | 0.010 |
Why?
|
Chromosomes, Human, Pair 22 | 1 | 2002 | 348 | 0.010 |
Why?
|
Chromosomes, Human, Pair 3 | 1 | 2002 | 323 | 0.010 |
Why?
|
Protein Processing, Post-Translational | 1 | 2009 | 1966 | 0.010 |
Why?
|
Time Factors | 3 | 2010 | 40218 | 0.010 |
Why?
|
Insulin-Like Growth Factor I | 1 | 2009 | 1942 | 0.010 |
Why?
|
Transfection | 1 | 2009 | 5755 | 0.010 |
Why?
|
Phenotype | 1 | 2019 | 16726 | 0.010 |
Why?
|
Chromosomes, Human, Pair 8 | 1 | 2002 | 452 | 0.010 |
Why?
|
Chromosomes, Human, Pair 9 | 1 | 2002 | 534 | 0.010 |
Why?
|
Microsatellite Repeats | 1 | 2002 | 785 | 0.010 |
Why?
|
Hematopoietic Stem Cells | 1 | 2012 | 3409 | 0.010 |
Why?
|
Catalytic Domain | 1 | 2002 | 699 | 0.010 |
Why?
|
Molecular Sequence Data | 1 | 2012 | 17622 | 0.010 |
Why?
|
Diagnosis, Differential | 1 | 2015 | 13014 | 0.010 |
Why?
|
Amino Acid Sequence | 1 | 2011 | 13421 | 0.010 |
Why?
|
Cell Membrane | 1 | 2009 | 3655 | 0.010 |
Why?
|
Lymphocyte Activation | 1 | 2010 | 5505 | 0.010 |
Why?
|
DNA Methylation | 1 | 2013 | 4428 | 0.010 |
Why?
|
Open Reading Frames | 1 | 2002 | 818 | 0.010 |
Why?
|
Interleukin-6 | 1 | 2009 | 3228 | 0.010 |
Why?
|
Vascular Endothelial Growth Factor A | 1 | 2009 | 3514 | 0.010 |
Why?
|
Cloning, Molecular | 1 | 2002 | 4168 | 0.010 |
Why?
|
RNA, Messenger | 1 | 2011 | 12800 | 0.010 |
Why?
|
Telomere | 1 | 2002 | 944 | 0.010 |
Why?
|
Magnetic Resonance Imaging | 1 | 2023 | 36743 | 0.010 |
Why?
|
United States | 1 | 2023 | 73039 | 0.010 |
Why?
|
Kinetics | 1 | 2002 | 6329 | 0.010 |
Why?
|
Hematopoietic Stem Cell Transplantation | 1 | 2012 | 5717 | 0.010 |
Why?
|
Treatment Outcome | 1 | 2021 | 65371 | 0.010 |
Why?
|
T-Lymphocytes | 1 | 2009 | 10266 | 0.010 |
Why?
|
Recombinant Proteins | 1 | 1999 | 6514 | 0.010 |
Why?
|
Retrospective Studies | 1 | 2015 | 81762 | 0.000 |
Why?
|
Follow-Up Studies | 1 | 1999 | 39348 | 0.000 |
Why?
|
Infant | 1 | 1999 | 36535 | 0.000 |
Why?
|